Unknown NA INTERVENTIONAL 2-arm NCT03915171

Sensitivity and Specificity of NGS in Detecting bMSI in Patients With Gastric, Duodenal and Small Intestinal Cancer

Sponsor: China Medical University, China

Interventions Next generation sequencing

Updated 5 times since 2019 Last updated: Apr 12, 2019 Started: Mar 1, 2019 Primary completion: Dec 1, 2019 Completion: Jun 1, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Gastrointestinal Cancer and is currently ongoing. China Medical University, China leads this study, which shows 5 recorded versions since 2019 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Recruiting NA
May 2019 — Jan 2021 [monthly]

Recruiting NA

First recorded

Mar 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

China Medical University, China

Data source: China Medical University, China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shenyang, China